The RECOVER I: A multicenter prospective study of Impella 5 The RECOVER I: A multicenter prospective study of Impella 5.0/LD for postcardiotomy circulatory support Bartley P. Griffith, MD, Mark B. Anderson, MD, Louis E. Samuels, MD, Walter E. Pae, MD, Yoshifumi Naka, MD, PhD, O. Howard Frazier, MD The Journal of Thoracic and Cardiovascular Surgery Volume 145, Issue 2, Pages 548-554 (February 2013) DOI: 10.1016/j.jtcvs.2012.01.067 Copyright © 2013 Terms and Conditions
Figure 1 Impella 5.0/LD left ventricular assist device (LVAD). (with permission from Abiomed, Danvers, Mass). The Journal of Thoracic and Cardiovascular Surgery 2013 145, 548-554DOI: (10.1016/j.jtcvs.2012.01.067) Copyright © 2013 Terms and Conditions
Figure 2 Average cardiac index and patient’s individual cardiac index on support values reflect the average cardiac index measurements obtained within the first 24 hours after device implantation. The Journal of Thoracic and Cardiovascular Surgery 2013 145, 548-554DOI: (10.1016/j.jtcvs.2012.01.067) Copyright © 2013 Terms and Conditions
Figure 3 Average mean arterial pressure (MAP) and patient’s individual MAP on support values reflect the average MAP measurements obtained within the first 6 hours after device implantation. The Journal of Thoracic and Cardiovascular Surgery 2013 145, 548-554DOI: (10.1016/j.jtcvs.2012.01.067) Copyright © 2013 Terms and Conditions
Figure 4 Average daily inotrope use. The Journal of Thoracic and Cardiovascular Surgery 2013 145, 548-554DOI: (10.1016/j.jtcvs.2012.01.067) Copyright © 2013 Terms and Conditions